171 related articles for article (PubMed ID: 26952712)
1. Hypertrophic neuropathy in Noonan syndrome with multiple lentigines.
Maridet C; Sole G; Morice-Picard F; Taieb A
Am J Med Genet A; 2016 Jun; 170(6):1570-2. PubMed ID: 26952712
[TBL] [Abstract][Full Text] [Related]
2. Paraspinal neurofibromas and hypertrophic neuropathy in Noonan syndrome with multiple lentigines.
Conboy E; Dhamija R; Wang M; Xie J; Dyck PJ; Bridges AG; Spinner RJ; Clayton AC; Watson RE; Messiaen L; Babovic-Vuksanovic D
J Med Genet; 2016 Feb; 53(2):123-6. PubMed ID: 26337637
[TBL] [Abstract][Full Text] [Related]
3. LEOPARD syndrome: clinical dilemmas in differential diagnosis of RASopathies.
Santoro C; Pacileo G; Limongelli G; Scianguetta S; Giugliano T; Piluso G; Ragione FD; Cirillo M; Mirone G; Perrotta S
BMC Med Genet; 2014 Apr; 15():44. PubMed ID: 24767283
[TBL] [Abstract][Full Text] [Related]
4. A PTPN11 allele encoding a catalytically impaired SHP2 protein in a patient with a Noonan syndrome phenotype.
Edwards JJ; Martinelli S; Pannone L; Lo IF; Shi L; Edelmann L; Tartaglia M; Luk HM; Gelb BD
Am J Med Genet A; 2014 Sep; 164A(9):2351-5. PubMed ID: 24891296
[TBL] [Abstract][Full Text] [Related]
5. Genetic landscape of RASopathies in Chinese: Three decades' experience in Hong Kong.
Yu KPT; Luk HM; Leung GKC; Mak CCY; Cheng SSW; Hau EWL; Chan DKH; Lam STS; Tong TMF; Chung BHY; Lo IFM
Am J Med Genet C Semin Med Genet; 2019 Jun; 181(2):208-217. PubMed ID: 30896080
[TBL] [Abstract][Full Text] [Related]
6. Clinical and molecular characterization of children with Noonan syndrome and other RASopathies in Argentina.
Chinton J; Huckstadt V; Moresco A; Gravina LP; Obregon MG
Arch Argent Pediatr; 2019 Oct; 117(5):330-337. PubMed ID: 31560489
[TBL] [Abstract][Full Text] [Related]
7. Compound heterozygosity for PTPN11 variants in a subject with Noonan syndrome provides insights into the mechanism of SHP2-related disorders.
Lorca R; Pannone L; Cuesta-Llavona E; Bocchinfuso G; Rodríguez-Reguero J; Carpentieri G; Hernando I; Flex E; Tartaglia M; Coto E; Gómez J; Martinelli S
Clin Genet; 2021 Mar; 99(3):457-461. PubMed ID: 33354767
[TBL] [Abstract][Full Text] [Related]
8. Genotype-phenotype association by echocardiography offers incremental value in patients with Noonan Syndrome with Multiple Lentigines.
Kauffman H; Ahrens-Nicklas RC; Calderon-Anyosa RJC; Ritter AL; Lin KY; Rossano JW; Quartermain MD; Banerjee A
Pediatr Res; 2021 Aug; 90(2):444-451. PubMed ID: 33318624
[TBL] [Abstract][Full Text] [Related]
9. Craniosynostosis in patients with RASopathies: Accumulating clinical evidence for expanding the phenotype.
Ueda K; Yaoita M; Niihori T; Aoki Y; Okamoto N
Am J Med Genet A; 2017 Sep; 173(9):2346-2352. PubMed ID: 28650561
[TBL] [Abstract][Full Text] [Related]
10. Lessons From a Genotype-Phenotype Study About the Clinical Spectrum of Hypertrophic Cardiomyopathy Associated With Noonan Syndrome With Multiple Lentigines and PTPN11-Mutations.
Östman-Smith I
Circ Genom Precis Med; 2023 Aug; 16(4):359-362. PubMed ID: 37325916
[No Abstract] [Full Text] [Related]
11. Cochlear implantation and clinical features in patients with Noonan syndrome and Noonan syndrome with multiple lentigines caused by a mutation in PTPN11.
van Nierop JWI; van Trier DC; van der Burgt I; Draaisma JMT; Mylanus EAM; Snik AF; Admiraal RJC; Kunst HPM
Int J Pediatr Otorhinolaryngol; 2017 Jun; 97():228-234. PubMed ID: 28483241
[TBL] [Abstract][Full Text] [Related]
12. A novel heterozygous MAP2K1 mutation in a patient with Noonan syndrome with multiple lentigines.
Nishi E; Mizuno S; Nanjo Y; Niihori T; Fukushima Y; Matsubara Y; Aoki Y; Kosho T
Am J Med Genet A; 2015 Feb; 167A(2):407-11. PubMed ID: 25423878
[TBL] [Abstract][Full Text] [Related]
13. Medulloblastoma in a patient with the PTPN11 p.Thr468Met mutation.
Rankin J; Short J; Turnpenny P; Castle B; Hanemann CO
Am J Med Genet A; 2013 Aug; 161A(8):2027-9. PubMed ID: 23813970
[TBL] [Abstract][Full Text] [Related]
14. Combined PTPN11 and MYBPC3 Gene Mutations in an Adult Patient with Noonan Syndrome and Hypertrophic Cardiomyopathy.
Caiazza M; Rubino M; Monda E; Passariello A; Fusco A; Cirillo A; Esposito A; Pierno A; De Fazio F; Pacileo R; Evangelista E; Pacileo G; Russo MG; Limongelli G
Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32824488
[TBL] [Abstract][Full Text] [Related]
15. Novel association of neurofibromatosis type 1-causing mutations in families with neurofibromatosis-Noonan syndrome.
Ekvall S; Sjörs K; Jonzon A; Vihinen M; Annerén G; Bondeson ML
Am J Med Genet A; 2014 Mar; 164A(3):579-87. PubMed ID: 24357598
[TBL] [Abstract][Full Text] [Related]
16. Independent NF1 and PTPN11 mutations in a family with neurofibromatosis-Noonan syndrome.
Thiel C; Wilken M; Zenker M; Sticht H; Fahsold R; Gusek-Schneider GC; Rauch A
Am J Med Genet A; 2009 Jun; 149A(6):1263-7. PubMed ID: 19449407
[TBL] [Abstract][Full Text] [Related]
17. [Case report and diagnosis of Noonan syndrome with multiple lentigines with deafness as its main clinical feature].
Huang SS; Huang BQ; Gao X; Yuan YY; Su Y; Wang GJ; Kang DY; Dai P
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Sep; 33(9):804-807. PubMed ID: 31446693
[No Abstract] [Full Text] [Related]
18. Pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: the multifaceted consequences of PTPN11 mutations.
Calcagni G; Digilio MC; Marino B; Tartaglia M
Orphanet J Rare Dis; 2019 Jul; 14(1):163. PubMed ID: 31277675
[TBL] [Abstract][Full Text] [Related]
19. Dermatological manifestations in Noonan syndrome: a prospective multicentric study of 129 patients positive for mutation.
Bessis D; Miquel J; Bourrat E; Chiaverini C; Morice-Picard F; Abadie C; Manna F; Baumann C; Best M; Blanchet P; Bursztejn AC; Capri Y; Coubes C; Giuliano F; Guillaumont S; Hadj-Rabia S; Jacquemont ML; Jeandel C; Lacombe D; Mallet S; Mazereeuw-Hautier J; Molinari N; Pallure V; Pernet C; Philip N; Pinson L; Sarda P; Sigaudy S; Vial Y; Willems M; Geneviève D; Verloes A; Cavé H
Br J Dermatol; 2019 Jun; 180(6):1438-1448. PubMed ID: 30417923
[TBL] [Abstract][Full Text] [Related]
20. Multiple spinal nerve enlargement and SOS1 mutation: Further evidence of overlap between neurofibromatosis type 1 and Noonan phenotype.
Santoro C; Giugliano T; Melone MAB; Cirillo M; Schettino C; Bernardo P; Cirillo G; Perrotta S; Piluso G
Clin Genet; 2018 Jan; 93(1):138-143. PubMed ID: 28456002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
